Ginkgo bioworks stocks.

Get the latest Ginkgo Bioworks (DNA+) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Ginkgo bioworks stocks. Things To Know About Ginkgo bioworks stocks.

Synthetic biology company Ginkgo Bioworks Holdings (DNA-4.79%) is down roughly 80% from its highs posted late last year. But rapidly growing revenues and a hefty cash balance, combined with ...Mar 17, 2022 · Not a stock for the Oracle of Omaha (yet) For the uninitiated, Ginkgo Bioworks is a deeply innovative biotech that specializes in automating the design and cultivation of synthetic bacteria and fungi. Principal Financial Group Inc. increased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 38.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 122,835 shares of the company’s stock after acquiring an additional …Mar 29, 2022 · Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...

Which Ginkgo Bioworks insiders have been buying company stock? The following insider purchased DNA shares in the last 24 months: Shyam Sankar ($512,000.00). How much insider buying is happening at Ginkgo Bioworks?

See the latest DNA Stock price for Ginkgo Bioworks Holdings Inc and NYSE: DNA stock rating, related news, valuation, dividends and more to help you make …

Sep 27, 2023 · Sep. 27, 2023, 07:01 AM. BOSTON, Sept. 27, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug ... When shares of innovative growth stocks like Ginkgo Bioworks ( DNA -4.79%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by ...Ginkgo Bioworks Quote Info ; Trades, 17,938 ; 52 Week Range, 1.12 - 2.545 ; VWAP, $ 1.43 ; Dollar Volume, $ 11,728,554 ; Volume, 8,188,147.Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA).Dec 1, 2023 · Many SPACs haven't lived up to their initial hype; unfortunately, Ginkgo hasn't been an exception. When its shares first began trading on the NYSE on Sept. 17, 2021, it opened at a price of $11.15 ...

Gingko Bioworks (NYSE:DNA) is bringing this science to the next level by introducing the power of AI to its toolkit. Ginkgo Bioworks promises that they can design and test microorganisms cheaper ...

As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...

On that note, on August 29 Ginkgo Bioworks ( DNA 5.80%) announced that it is joining forces with Alphabet, Google's parent company, in a five-year strategic partnership to develop and use new ...There was plenty of action in Ginkgo Bioworks ( DNA -2.06%) stock on Thursday, but not the kind the company probably like. Investors sold out of the biotech following the publication of its latest ...Aug 29, 2023 ... A key announcement is driving shares of DNA stock more than 20% higher today. Ginkgo Bioworks is making waves in the AI world.Oct 06, 2021, 5:24 pm EDT. Shares of Ginkgo Bioworks Holdings closed down almost 12% after Scorpion Capital, a research firm focused on short selling, slammed the company as heavily reliant on ...Jul 13, 2022 · Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ... Ginkgo Bioworks stock plummeted as much as 24% Wednesday after Scorpion Capital alleged the company is a "Frankenstein mash-up of the worst frauds." Ginkgo went public last month via SPAC and ...Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ...Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ...Food ingredient company Vivici has partnered with Ginkgo Bioworks to develop a range of new alternative dairy proteins created through precision fermentation, …Which Ginkgo Bioworks insiders have been buying company stock? The following insider purchased DNA shares in the last 24 months: Shyam Sankar ($512,000.00). How much insider buying is happening at Ginkgo Bioworks?Discover historical prices for DNA stock on Yahoo Finance. View daily, weekly or monthly format back to when Ginkgo Bioworks Holdings, Inc. stock was issued.Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021.

News ; 17.11.2023. 3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report ; 13.11.2023. 3 Cathie Wood Bargain Buys That Should Be on Your List Too ; 09.11 ...

1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.The Ark Invest CEO is also known for having a bit of a contrarian streak, buying shares of stocks right as the market is dumping them, which is exactly what she's doing with Ginkgo Bioworks (DNA 5 ...Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ginkgo Bioworks Holdings Inc (NYSE:DNA) Real-Time Quotes. 1.37.Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ...Nov 6, 2023 · You can see the complete list of today’s Zacks #1 Rank stocks here. Ginkgo Bioworks Holdings, Inc. Price and EPS Surprise. Ginkgo Bioworks Holdings, Inc. Price and EPS Surprise. Nov 24, 2023 · Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion. Ginkgo Bioworks has a fantastic reputation of committing money to R&D. As an investor, I would look past current share pricing and focus on the potential 12-month upside of the company's technology.

Get the latest Ginkgo Bioworks (DNA+) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Ginkgo Bioworks Holdings ... Following the text book for innovative stocks in 2022, Ginkgo shed 80% of its value last year. Wood, though, has been getting the checkbook out; over the past 3 months ...

Aug 29, 2023 ... A key announcement is driving shares of DNA stock more than 20% higher today. Ginkgo Bioworks is making waves in the AI world.Mar 17, 2022 · Not a stock for the Oracle of Omaha (yet) For the uninitiated, Ginkgo Bioworks is a deeply innovative biotech that specializes in automating the design and cultivation of synthetic bacteria and fungi. 1. Ginkgo Bioworks. Ginkgo Bioworks ( DNA) saw its shares fall by 69% over the last 12 months, but that could be just the opening that value-hunting investors need to start a position. Unlike ...Examples of gymnosperms are fir trees, spruce trees, pine trees, cycads and ginkgo trees. Examples of angiosperms include oak trees, maples, birches, forsythias, daisies, lilies and lilac bushes.Sep 27, 2023 · Ginkgo Bioworks. Market Cap. $3B. Today's Change. (5.80%) $0.08. Current Price. $1.46. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ... Not a stock for the Oracle of Omaha (yet) For the uninitiated, Ginkgo Bioworks is a deeply innovative biotech that specializes in automating the design and cultivation of synthetic bacteria and fungi.Aug 29, 2023 · Shares of Ginkgo Bioworks ( NYSE: DNA) added ~10% pre-market Tuesday after the cell platform company and Google Cloud, a unit of tech giant Alphabet Inc. ( NASDAQ: GOOG) ( NASDAQ: GOOGL ... Oct 13, 2021 · The honeymoon for newly minted Ginkgo Bioworks ( DNA 4.11%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ... Ginkgo Bioworks Holdings Inc stock has a Growth Score of 24, Estimate Revisions Score of 29 and Quality Score of 13. Comparing United Therapeutics Corporation and Ginkgo Bioworks Holdings Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your ...Stock Info; SEC Filings. SEC Filings; Quarterly Reports; Annual Reports; Sustainability; Governance. Executive Management; Board of Directors; Committee …

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...According to the issued ratings of 5 analysts in the last year, the consensus rating for Ginkgo Bioworks stock is Hold based on the current 1 sell rating, 3 hold ratings and 1 buy rating for DNA. The average twelve-month price prediction for Ginkgo Bioworks is $3.19 with a high price target of $6.00 and a low price target of $1.25. Learn more ...Ginkgo Bioworks' stock was trading at $1.69 at the start of the year. Since then, DNA shares have decreased by 15.4% and is now trading at $1.43. View the best …Instagram:https://instagram. schwab in the newsbenzinga pro costamrsqpimix fund Ginkgo Bioworks. Market Cap. $3B. Today's Change. (5.80%) $0.08. Current Price. $1.46. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...Ginkgo Bioworks saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 235,940,000 shares, an increase of 2.2% from the previous total of 230,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ... adm stocksmerrill private wealth management Sep 27, 2023 · Sep. 27, 2023, 07:01 AM. BOSTON, Sept. 27, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug ... Apr 12, 2023 · Boston-based Ginkgo Bioworks (NYSE: DNA) is working to develop a platform to “program cells to make everything from food to materials to therapeutics.” Industries it serves include agriculture ... quarter dated 1776 to 1976 The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the last day by ...Nov 29, 2023 · Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts.